PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7882901-5	1994	When tested by RIA or by the Nb2 bioassay, there appeared to be approximately 50% less PRL secreted (2 weeks post-injection) by cells of the NMU-treated than the vehicle-treated animals.	Methylnitrosourea	141-144	prolactin	Rattus norvegicus	87-90	
7882901-6	1994	However, when tested by IL-2R assay, PRL cells of NMU-treated animals secreted 50% more activity.	Methylnitrosourea	50-53	prolactin	Rattus norvegicus	37-40	
7882901-9	1994	Our interpretation is that NMU treatment interferes with the feedback of lymphokines on the pituitary with a decrease in the form of PRL detected by the RIA and Nb2 assays and an increase in the form which activates splenocytes, and thus changes the composition and function of the immune system.	Methylnitrosourea	27-30	prolactin	Rattus norvegicus	133-136